1. OP0227 Oral C5a Receptor Antagonist CCX168 Phase 2 Clinical TRIAL in Anca-Associated Renal Vasculitis. (10th June 2014) Authors: Jayne, D.R.; Bruchfeld, A.; Schaier, M.; Ciechanowski, K.; Harper, L.; Jadoul, M.; Segelmark, M.; Selga, D.; Szombati, I.; Venning, M.; Hugo, C.; Van Daele, P.L.; Viklicky, O.; Potarca, A.; Schall, T.J.; Bekker, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗